We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
- Authors
McCloskey, R V; Straube, R C; Sanders, C; Smith, S M; Smith, C R
- Abstract
To compare the effectiveness of 100 mg of HA-1A and placebo in reducing the 14-day all-cause mortality rate in patients with septic shock and gram-negative bacteremia in the Centocor: HA-1A Efficacy in Septic Shock (CHESS) trial, and to assess the safety of 100 mg of HA-1A given to patients with septic shock who did not have gram-negative bacteremia.
- Publication
Annals of internal medicine, 1994, Vol 121, Issue 1, p1
- ISSN
0003-4819
- Publication type
Journal Article
- DOI
10.7326/0003-4819-121-1-199407010-00001